Search the Newsreel

ImmuCell Corp (ICCC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for ImmuCell Corp (ICCC), detailing its performance by business segments and regional contributions. The data, updated on April 6, shows that the First Defense® product line accounts for the vast majority of its revenue, and the United States …

Immuron CEO Steven Lydeamore Presents at TechKnow Invest Roadshow as Company Advances Polyclonal Antibody Pipeline

Immuron Limited's CEO, Steven Lydeamore, presented at the TechKnow Invest Roadshow, highlighting the company's progress in oral polyclonal antibody therapies. The presentation covered their commercial product Travelan® for travelers' diarrhea, the investigational drug IMM-529 for recurrent Clostridioides difficile infection, and the distributed product ProIBS® …

Immuron (NASDAQ: IMRN) outlines FY26 growth, cash runway and CDI IND plans

Immuron Limited shared an investor update detailing FY26 sales, cash position, and plans for its clinical assets. The company reported global sales revenue of A$7.7 million for FY26, a 6% increase from the previous year, and maintains a strong cash balance of A$10.0 million …

Immersion Will Pay a $0.075 Dividend After 15 Straight Quarters

Immersion Corporation reported its Q4 and fiscal year 2026 financial results, with GAAP net income attributable to stockholders reaching $3.7 million ($0.12 per diluted share) for Q4. The company announced a quarterly dividend of $0.075 per share, its 15th consecutive dividend, to be paid …

Immersion Corporation (Nasdaq: IMMR) grows revenue to $1.7B in fiscal 2026

Immersion Corporation reported its financial results for the fourth quarter and fiscal year ended April 30, 2026, announcing total revenue of $1.7 billion for fiscal 2026, an increase from $1.6 billion in fiscal 2025. This growth was largely due to the consolidation of Barnes …

Immersion Reports Q4 and FY2026 Results: Q4 GAAP Net Income $3.7M, Revenue $270.0M

Immersion (IMMR) reported its financial results for Q4 and fiscal year 2026. For Q4, the company saw GAAP net income of $3.7 million on revenues of $270.0 million, with full-year 2026 revenues reaching $1.73 billion. Key highlights include the financial impact of the Barnes …

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.79 Million Tokens, and Total Crypto and Total Cash Holdings of $11.8 Billion

Bitmine Immersion Technologies (BMNR) announced that its Ethereum (ETH) holdings have reached 5.79 million tokens, contributing to total crypto and cash holdings of $11.8 billion. The company has acquired 4.8% of the total ETH coin supply and is progressing towards its "Alchemy of 5%" …

Press Release: Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors

Immunic, Inc. has appointed Michael W. Bonney as Chair of its Board of Directors. Bonney brings extensive experience from his previous leadership roles at Kaleido Biosciences, Baxalta Inc., and Cubist Pharmaceuticals, as well as his current positions on the boards of several prominent biotechnology …

Shimmick Awarded $124M Flood Project Covering About Nine Miles

Shimmick (NASDAQ: SHIM) has announced over $265 million in new project awards, significantly expanding its backlog. Key projects include a $124 million flood protection project in San José, a $42 million wastewater treatment plant expansion in Texas, and an $80 million share in the …

Altimmune Market Sentiment

This article provides an overview of the market sentiment for Altimmune (ALT), including analyst consensus, short interest, options flow, and insider activity. It highlights a strong "Buy" consensus from analysts with ambitious price targets and notes a significant short interest of 24.5%. The article …

Immunocore Holdings PLC (IMCR) Cash Flow

This article provides a detailed cash flow statement for Immunocore Holdings PLC (IMCR), covering operating, investing, and financing activities across various quarters and fiscal years. It includes specific financial figures and percentage changes for different cash flow components. Additionally, the article offers FAQs explaining …

Lyell Immunopharma Inc (LYEL) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Lyell Immunopharma Inc (LYEL), covering operating, investing, and financing activities. It presents financial data for various quarters, highlighting net income, capital expenditures, and changes in working capital. The report also includes FAQs …

Immatics NV (IMTX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Immatics NV (IMTX), listing its major shareholders and their proportional holdings. It also provides a breakdown of shareholder types, institutional shareholding data over several quarters, and recent shareholder activity from key investors. Additionally, the article identifies related …

SCNI|Scinai Immunotherapeutics Ltd|Price:0.245|Chg%:-0.014

Scinai Immunotherapeutics Ltd (SCNI) is a biopharmaceutical company focused on developing medical products for autoimmune and infectious diseases, particularly NanoAbs for conditions like COVID-19 and psoriasis. Despite a recent stock price decline, the company shows strong fundamentals and significant growth potential, although analysts currently …

Immunic Inc (IMUX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for Immunic Inc (IMUX). It states that the company has not distributed any dividends in the past five years. However, it lists a significant 10-for-1 merger type stock split scheduled for April 14, 2026.

Immuron Ltd (IMRN) Institutional Confidence

This article focuses on the institutional confidence in Immuron Ltd (IMRN), detailing the shareholding and activity of various financial institutions. Key institutions like Morgan Stanley & Co. LLC and Citadel Advisors LLC significantly increased their holdings, while others like XTX Markets LLC and Rhumbline …

96,341 Shares in BitMine Immersion Technologies, Inc. $BMNR Acquired by Entropy Technologies LP

Entropy Technologies LP has acquired 96,341 shares of BitMine Immersion Technologies Inc. (BMNR) during the first quarter, valued at around $1.91 million. Other institutional investors like Sumitomo Mitsui Trust Group also increased their holdings. Although analyst sentiment for BMNR is mixed but leans positive, …

Scinai Immunotherapeutics Ltd (SCNI) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for Scinai Immunotherapeutics Ltd (SCNI). It notes that SCNI has distributed $0.00 in dividends over the past five years and details several merger-related stock splits with a 10:1 ratio that occurred in May 2024 and …

Estrella Immunopharma Inc (ESLA) Balance Sheet

This article provides detailed quarterly and annual balance sheet data for Estrella Immunopharma Inc (ESLA), allowing investors to analyze its financial health, liquidity, leverage, and return on equity. The balance sheet includes metrics such as cash and short-term investments, total assets, various liabilities, and …

ImmuCell Corp (ICCC) Cash Flow

This article provides an in-depth look at ImmuCell Corp's (ICCC) cash flow statements, including operating, investing, and financing activities, across various fiscal quarters and years. It also defines key cash flow metrics like operating, investing, and financing cash flow, as well as free cash …

BitMine Immersion Technologies (NYSE:BMNR) Shares Gap Up - Here's What Happened

Estrella Immunopharma Inc (ESLA) Cash Flow - Tradingkey.com

This article provides a detailed cash flow statement for Estrella Immunopharma Inc (ESLA), presenting quarterly and annual financial data for operating, investing, and financing activities. It includes key metrics like operating cash flow, net income, and changes in working capital, along with definitions for …

Immunic Inc (IMUX) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Immunic Inc (IMUX), detailing various financial metrics related to volatility, maximum drawdown, and liquidity. Key figures include a Beta vs S&P 500 index of 1.35, a 240-Day Volatility of +95.96%, and a 5-year maximum drawdown of +96.42%. …

Immunocore Holdings PLC (IMCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article provides a revenue breakdown for Immunocore Holdings PLC (IMCR), focusing on regional contributions. As of April 6, the company's revenue is primarily driven by the United States (64.25%) and Europe (32.85%), with a smaller portion from International markets. Information regarding collaboration revenue …

Immatics NV (IMTX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the dividend and stock split history for Immatics NV (IMTX). It indicates that the company has not distributed any dividends over the past five years. The page displays various financial metrics for IMTX, including its market capitalization, and stock …

BITMINE IMMERSION TECHNOLOGIES INC 9.5 SER A CUM PREF STK To Go Ex-Dividend On July 28th, 2026 With 0.1847 USD Dividend Per Share

BITMINE IMMERSION TECHNOLOGIES INC 9.5 SER A CUM PREF STK (OTCMKTS:BTMN-PA) is scheduled to go ex-dividend on July 28th, 2026. Shareholders of record on July 29th, 2026, will receive a dividend of $0.1847 per share, payable on August 9th, 2026. This announcement highlights the …

Stock Score & Comprehensive Stock Analysis of Shimmick Corp (SHIM) - Tradingkey

This article provides a comprehensive stock analysis of Shimmick Corp (SHIM) by TradingKey, highlighting its relatively stable fundamentals, good growth potential, and "fairly valued" status within the Construction & Engineering industry. Despite high institutional ownership and recent "Buy" ratings from analysts, the stock is …

IBRX Stock Rises Overnight: Retail Traders Hunt For Global Expansion Clues Ahead Of Biotech Conference

ImmunityBio (IBRX) stock saw an overnight rise as retail traders anticipate announcements regarding the company's global expansion and partnerships at the upcoming BTIG Virtual Biotechnology Conference. Despite a recent dip, investor chatter highlights expectations for significant updates, especially concerning ImmunityBio's Anktiva immunotherapy, its NK-cell …

Zimmer Biomet Holdings Inc (ZBH) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Zimmer Biomet Holdings Inc (ZBH), highlighting its major institutional investors and their respective holdings. It also breaks down shareholder types and provides a quarterly overview of institutional shareholding trends and changes in individual shareholder activity.

Shimmick Corp (SHIM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article provides a revenue breakdown for Shimmick Corp (SHIM) by business segment, including fixed-price, cost reimbursable, and equipment and labor revenue. It shows the proportion of revenue generated by each segment, with fixed-price contracts accounting for the vast majority. The data was updated …

Immunic Inc (IMUX) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Immunic Inc (IMUX), including sections on operating, investing, and financing cash flows. It also offers a FAQ section defining these terms and providing specific cash flow figures for Immunic Inc, such as …

Immuron Ltd (IMRN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Immuron Ltd (IMRN), indicating a "Buy" rating based on one analyst's assessment. The target price for IMRN is set at USD 5.00, representing a significant upside. The report includes current market data and a peer comparison, but …

Immuron Ltd (IMRN) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Immuron Ltd (IMRN), focusing on its volatility, financial risk, and investment risk based on various metrics. It details the company's market performance, including daily returns, drawdowns, Sharpe Ratios, and different measures of volatility and liquidity. The data …

BitMine Nearing Inflection Point as Ethereum Buying Nears Key Target

BitMine Immersion (BMNR) is approaching a significant turning point as it nears its target of accumulating 6 million Ethereum (ETH) coins. This move is expected to end share dilution and allow the company to transition into a cash generator through Ethereum staking, yielding an …

MindWalk Holdings Corp. 2026 Q4 - Results - Earnings Call Presentation (NASDAQ:HYFT) 2026-07-26

This article announces that MindWalk Holdings Corp. has published its slide deck in conjunction with their 2026 Q4 earnings call. The content is an earnings call presentation for the company, traded under the NASDAQ symbol HYFT, dated July 26, 2026.

Immuron Ltd (IMRN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Immuron Ltd (IMRN), focusing on various indicators and moving averages. It presents a summary of "Sell," "Neutral," and "Buy" signals from nine common technical indicators and six moving averages. The analysis concludes with a "Neutral" signal based …